128 related articles for article (PubMed ID: 31006875)
1. Detection of extranodal and spleen involvement by FDG-PET imaging predicts adverse survival in untreated follicular lymphoma.
St-Pierre F; Broski SM; LaPlant BR; Ristow K; Maurer MJ; Macon WR; Habermann TM; Ansell SM; Thompson CA; Micallef INM; Nowakowski GS; Witzig TE
Am J Hematol; 2019 Jul; 94(7):786-793. PubMed ID: 31006875
[TBL] [Abstract][Full Text] [Related]
2. Fluorodeoxyglucose-Positron Emission Tomography Predicts Bone Marrow Involvement in the Staging of Follicular Lymphoma.
St-Pierre F; Broski SM; LaPlant BR; Maurer MJ; Ristow K; Thanarajasingam G; Macon WR; Habermann TM; Witzig TE
Oncologist; 2020 Aug; 25(8):689-695. PubMed ID: 32319706
[TBL] [Abstract][Full Text] [Related]
3. Baseline FDG-PET/CT detects bone marrow involvement in follicular lymphoma and provides relevant prognostic information.
Nakajima R; Moskowitz AJ; Michaud L; Mauguen A; Batlevi CL; Dogan A; Schöder H
Blood Adv; 2020 Apr; 4(8):1812-1823. PubMed ID: 32343798
[TBL] [Abstract][Full Text] [Related]
4. Basal (18)F-FDG PET/CT in follicular lymphoma: A comparison of metabolic and clinical variables in the prognostic assessment.
Jiménez Londoño GA; García Vicente AM; Poblete García VM; Amo-Salas M; Calle Primo C; Ibañez García Á; Martínez Sanchís B; López-Fidalgo JF; Solano Ramos F; Martínez Hellín A; Díaz Morfa M; Soriano Castrejón Á
Rev Esp Med Nucl Imagen Mol; 2016; 35(5):298-305. PubMed ID: 27312693
[TBL] [Abstract][Full Text] [Related]
5. Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy.
Teagle AR; Barton H; Charles-Edwards E; Dizdarevic S; Chevassut T
Acta Radiol; 2017 Dec; 58(12):1476-1484. PubMed ID: 28382828
[TBL] [Abstract][Full Text] [Related]
6. FDG-PET/CT at the end of immuno-chemotherapy in follicular lymphoma: the prognostic role of the ratio between target lesion and liver SUV
Annunziata S; Cuccaro A; Tisi MC; Hohaus S; Rufini V
Ann Nucl Med; 2018 Jun; 32(5):372-377. PubMed ID: 29464479
[TBL] [Abstract][Full Text] [Related]
7. [18F] Positron emission tomography response after rituximab-containing induction therapy in follicular lymphoma is an independent predictor of survival after adjustment for FLIPI in academic and community-based practice.
Wong-Sefidan I; Byrtek M; Zhou X; Friedberg JW; Flowers CR; Zelenetz AD; Dawson KL; Reid E
Leuk Lymphoma; 2017 Apr; 58(4):809-815. PubMed ID: 27562750
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of standardized uptake value on F18-FDG PET/CT in patients with extranodal nasal type NK/T cell lymphoma: A multicenter, retrospective analysis.
Pak K; Kim BS; Kim K; Kim IJ; Jun S; Jeong YJ; Shim HK; Kim SD; Cho KS
Am J Otolaryngol; 2018; 39(1):1-5. PubMed ID: 29056243
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of mid- and post-treatment [(18)F]fluorodeoxyglucose (FDG) positron emission tomography (PET) in indolent follicular lymphoma.
Lu Z; Lin M; Downe P; Chong S; Ling S
Ann Nucl Med; 2014 Oct; 28(8):805-11. PubMed ID: 25008291
[TBL] [Abstract][Full Text] [Related]
10. The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: a subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL).
Luminari S; Biasoli I; Versari A; Rattotti S; Bottelli C; Rusconi C; Merli F; Spina M; Ferreri AJ; Zinzani PL; Gallamini A; Franceschetto A; Boccomini C; Franceschetti S; Salvi F; Raimondo FD; Carella AM; Micol Q; Balzarotti M; Musto P; Federico M
Ann Oncol; 2014 Feb; 25(2):442-7. PubMed ID: 24412823
[TBL] [Abstract][Full Text] [Related]
11. Outcome of patients with early-stage follicular lymphoma staged with
Ng SP; Khor R; Bressel M; MacManus M; Seymour JF; Hicks RJ; Wirth A
Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):80-86. PubMed ID: 30083824
[TBL] [Abstract][Full Text] [Related]
12. The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi.
Luminari S; Biasoli I; Arcaini L; Versari A; Rusconi C; Merli F; Spina M; Ferreri AJ; Zinzani PL; Gallamini A; Mastronardi S; Boccomini C; Gaidano G; D'Arco AM; Di Raimondo F; Carella AM; Santoro A; Musto P; Federico M
Ann Oncol; 2013 Aug; 24(8):2108-12. PubMed ID: 23585513
[TBL] [Abstract][Full Text] [Related]
13. Comparison of PET/MRI With PET/CT in the Evaluation of Disease Status in Lymphoma.
Afaq A; Fraioli F; Sidhu H; Wan S; Punwani S; Chen SH; Akin O; Linch D; Ardeshna K; Lambert J; Miles K; Groves A; Kayani I
Clin Nucl Med; 2017 Jan; 42(1):e1-e7. PubMed ID: 27607161
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Importance of Bone Marrow Uptake on Baseline
Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO
Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma.
Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: analysis of PET-CT in a subset of PRIMA trial participants.
Trotman J; Fournier M; Lamy T; Seymour JF; Sonet A; Janikova A; Shpilberg O; Gyan E; Tilly H; Estell J; Forsyth C; Decaudin D; Fabiani B; Gabarre J; Salles B; Van Den Neste E; Canioni D; Garin E; Fulham M; Vander Borght T; Salles G
J Clin Oncol; 2011 Aug; 29(23):3194-200. PubMed ID: 21747087
[TBL] [Abstract][Full Text] [Related]
17. Value of [18F]fluorodeoxyglucose positron emission tomography in the management of follicular lymphoma: the end of a dilemma?
Janikova A; Bolcak K; Pavlik T; Mayer J; Kral Z
Clin Lymphoma Myeloma; 2008 Oct; 8(5):287-93. PubMed ID: 18854283
[TBL] [Abstract][Full Text] [Related]
18. Outcome prediction by extranodal involvement, IPI, R-IPI, and NCCN-IPI in the PET/CT and rituximab era: A Danish-Canadian study of 443 patients with diffuse-large B-cell lymphoma.
El-Galaly TC; Villa D; Alzahrani M; Hansen JW; Sehn LH; Wilson D; de Nully Brown P; Loft A; Iyer V; Johnsen HE; Savage KJ; Connors JM; Hutchings M
Am J Hematol; 2015 Nov; 90(11):1041-6. PubMed ID: 26260224
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic Value of Maximum Standard Uptake on Pretreatment ¹⁸F-FDG PET/CT Scan in Newly Diagnosed Follicular Lymphoma].
Ding CY; Sun J; Li TN; Xu W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1331-5. PubMed ID: 26524032
[TBL] [Abstract][Full Text] [Related]
20. Follicular lymphoma transforming into diffuse large B-cell lymphoma in spleen: Simultaneous appearance of both on
Makis W; Ciarallo A; Petrogiannis-Haliotis T; Rosenberg A; Probst S
Clin Imaging; 2017; 43():88-92. PubMed ID: 28259031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]